Join us for the CureGN Patient and Family Fireside Chat
CureGN study patients and family members are invited to join a virtual meeting:
Date: March 31, 2022 from 4-5:30 PM (EST)
CureGN study patients and family members are invited to join a virtual meeting:
Date: March 31, 2022 from 4-5:30 PM (EST)
The Cure Glomerulonephropathy Network (CureGN) project currently has over 2,400 children and adults enrolled with the following glomerular diseases:
Minimal change disease (MCD)
Focal segmental glomerulosclerosis (FSGS)
Membranous nephropathy (MN)
IgA nephropathy (IgAN and IgAV)
Participants are followed longitudinally to better understand the causes of disease, response to therapy, and disease progression, with the ultimate objective to cure glomerulonephropathy.
A team of medical research professionals has been assembled to study glomerular diseases
Information and results based on CureGN study data are available in several publications. A curated list of these published works is available on the For Researchers page.
Unfortunately, Internet Explorer is an outdated browser and we do not currently support it. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.
Upgrade